A case series of third-trimester raltegravir initiation: Impact on maternal HIV-1 viral load and obstetrical outcomes

por Boucoiran, I, Tulloch, K, Pick, N, Kakkar, F, van Schalkwyk, J, Money, D, Boucher, M
Publicado 2015

Initial multicenter experience with double nucleoside therapy for human immunodeficiency virus infection during pregnancy.

por Silverman, N S, Watts, D H, Hitti, J, Money, D M, Livingston, E, Axelrod, J, Ernest, J M, Robbins, D, DiVito, M M
Publicado 1998

Canadian surveillance of COVID-19 in pregnancy: Epidemiology and maternal and infant outcomes

por McClymont, E., Fell, D.B., Albert, A., Alton, G.D., Barrett, J., El-Chaar, D., Harrold, J., Krajden, M., Lipsky, N., Maan, E., Malinowski, A.K., Othman, M., Raeside, A., Ray, J., Roberts, A., Ryan, G., Sadarangani, M., Sauve, L., van Schalkwyk, J., Shah, P., Snelgrove, J.W., Sprague, A., Ting, J., Walker, M., Whittle, W., Williams, C., Yudin, M.H., Zipursky, J.S., Abenhaim, H.A., Boucoiran, I., Castillo, E., Crane, J., Elwood, C., Joynt, C., Kotaska, A., Martel, J., Murphy-Kaulbeck, L.C., Poliquin, V., Ryan, S.R., Saunders, S., Scott, H., Money, D.
Publicado 2020